Edwards Lifesciences Corp EW

NYSE US Health Care

$86.07 ▼ -0.98% ($-0.85)

Index member: S&P 500

Open $87.08

Prev Close $86.92

Day Range $85.24 – $87.08

52W Range $72.30 – $96.29

Market Cap $50.05B

P/E (TTM) 49.41

Beta 0.84

EPS (TTM) $1.73

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	2000-03-27
Shares Out.	575,800,000
Website	edwards.com ↗
Phone	13026587581
Employees	16,000
Revenue	$1.65B
Gross Profit	$1.29B
Net Income	$380.7M
Free Cash Flow	$1.09B
Total Assets	$13.32B
Total Liabilities	$2.99B
Equity	$10.33B

About Edwards Lifesciences Corp

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Edwards Lifesciences Corp is a publicly traded company under the ticker symbol EW on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.